- 24/7 Wall St.•2 days ago
Some companies are hitting lows and creating huge shareholder losses while the market is just below all-time highs but still struggling. These are the same companies holding back the market and punishing ...
- MarketWatch•5 days ago
Rigel Pharmaceuticals’ stock plunges after its ITP treatment, which it cut nearly half its workforce to focus on, missed the primary goal in a phase 3 trial.
Rigel Pharmaceuticals, Inc. (RIGL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||2.59 x 1000|
|Ask||2.70 x 200|
|Day's Range||2.53 - 2.77|
|52wk Range||1.88 - 4.38|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-4.81|
|Avg Vol (3m)||2,466,736|
|Dividend & Yield||N/A (N/A)|